Results
The age and body mass index (BMI) of 150 patients in this study ranged from 16 to 80 y (49.83 ± 14.53) and 12.41 to 41.79 kg/m2 (25.09 ± 5.32), respectively. Tables 1 and 2 show the participants’ demographic, clinical, and medical characteristics.
Table 1 near here.
Among the participants, 17.3% (n=26) had hematologic cancers. Cancer incidence ranged from 1 to 180 months (23.26 ± 29.3). The frequency of chemotherapy and radiotherapy sessions varied from 1 to 13 (3.61 ± 2.37), 0 to 70 (8.24 ± 9.79), and 0 to 50 (5.50 ± 11.5) times, respectively, for patients admitted to the hospital due to cancer.
Table 2 near here.
Total MEQ scores ranged between 41 and 74 (56.6 ± 6.34). In this study, 2% (n=3) of patients were definitely morning types, 38% (n=57) were moderately morning types, 59.3% (n=89) were neither types, 0.7% (n=1) was moderately evening types, and no patients were definitely evening types. Normal distribution was observed for MEQ scores among the participants (Figure 1).
Figure 1 near here.
According to Table 3 and 4, the mean ages of completely and moderately morning types were greater than those of all other types. The distribution of circadian rhythms was nearly identical between male and female participants. Employed and unemployed individuals, as well as patients with varying levels of education, were frequently morning and neither types. The ANOVA test did not reveal significant associations between chronotype and age, time of cancer onset, cancer-specific hospitalization, chemotherapy, or radiotherapy sessions. Furthermore, Fisher’s exact test revealed no correlation between employment status, marital status, gender, treatment methods, level of education, patient condition, and types of circadian rhythm.
Table 3 and 4 near here.